Investigating the feasibility of gene therapy for stereocilin-related hearing loss
In this project, Professor Els Henckaerts at KU Leuven, Belgium, is testing gene therapy as a method to treat hearing loss caused by mutations in the ‘stereocilin’ gene. Project start date: March 2026 Project end date: February 2028 About the project One of the most common geneti
